<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">vguit</journal-id><journal-title-group><journal-title xml:lang="ru">Вестник Воронежского государственного университета инженерных технологий</journal-title><trans-title-group xml:lang="en"><trans-title>Proceedings of the Voronezh State University of Engineering Technologies</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2226-910X</issn><issn pub-type="epub">2310-1202</issn><publisher><publisher-name>VSUET</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.20914/2310-1202-2024-1-84-88</article-id><article-id custom-type="elpub" pub-id-type="custom">vguit-3374</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>Пищевая  биотехнология</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>Food biotechnology</subject></subj-group></article-categories><title-group><article-title>Метаболические процессы в костной ткани при воздействии гипертермии и введении аллогенного кальцийсодержащего биоматериала «Лиопласт»</article-title><trans-title-group xml:lang="en"><trans-title>Metabolic processes in bone tissue under exposure to hyperthermia and administration of allogenic calcium-containing biomaterial "Lyoplast"</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Писарева</surname><given-names>Е. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Pisareva</surname><given-names>E. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>к.б.н., заведующий, кафедра биохимии, биотехнологии и биоинженерии, Московское шоссе, 34, г. Самара, 443086, Россия</p></bio><bio xml:lang="en"><p>Cand. Sci. (Biol.), head, biochemistry, biotechnology and bioengineering department, Moscow Hwy, 34, Samara, 443086, Russia</p></bio><email xlink:type="simple">noreplay5@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Власов</surname><given-names>М. Ю.</given-names></name><name name-style="western" xml:lang="en"><surname>Vlasov</surname><given-names>M. Y.</given-names></name></name-alternatives><bio xml:lang="ru"><p>к.б.н., доцент, кафедра биохимии, биотехнологии и биоинженерии, Московское шоссе, 34, г. Самара, 443086, Россия; ведущий научный сотрудник, научно-исследовательский институт биотехнологий, Самарский государственный медицинский университет, ул. Чапаевская, 89, г. Самара, 443099, Россия</p></bio><bio xml:lang="en"><p>Cand. Sci. (Biol.), associate professor, biochemistry, biotechnology and bioengineering department, Moscow Hwy, 34, Samara, 443086, Russia; lead scientist, biotechnology research institute, Samara State Medical University, Chapaevskaya St, 89, Samara, 443099, Russia</p></bio><email xlink:type="simple">noreplay4@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Волова</surname><given-names>Л. Т.</given-names></name><name name-style="western" xml:lang="en"><surname>Volova</surname><given-names>L. T.</given-names></name></name-alternatives><bio xml:lang="ru"><p>д.м.н., профессор, директор, научно-исследовательский институт биотехнологий, ул. Чапаевская, 89, г. Самара, 443099, Россия</p></bio><bio xml:lang="en"><p>Dr. Sci. (Med.), director, biotechnology research institute, Chapaevskaya St, 89, Samara, 443099, Russia</p></bio><email xlink:type="simple">noreplay3@neicon.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Ищенко</surname><given-names>К. С.</given-names></name><name name-style="western" xml:lang="en"><surname>Ishchenko</surname><given-names>K. S.</given-names></name></name-alternatives><bio xml:lang="ru"><p>магистр, кафедра экологии, ботаники и охраны природы, Московское шоссе, 34, г. Самара, 443086, Россия</p></bio><bio xml:lang="en"><p>master student, ecology, botany and nature conservation department, Moscow Hwy, 34, Samara, 443086, Russia</p></bio><email xlink:type="simple">noreplay2@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Сергеева</surname><given-names>С. С.</given-names></name><name name-style="western" xml:lang="en"><surname>Sergeeva</surname><given-names>S. S.</given-names></name></name-alternatives><bio xml:lang="ru"><p>магистр, м кафедра биохимии, биотехнологии и биоинженерии, Московское шоссе, 34, г. Самара, 443086, Россия</p></bio><bio xml:lang="en"><p>master student, biochemistry, biotechnology and bioengineering department, Moscow Hwy, 34, Samara, 443086, Russia</p></bio><email xlink:type="simple">noreplay1@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Самарский национальный исследовательский университет</institution></aff><aff xml:lang="en"><institution>Samara National Research University</institution></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>Самарский государственный медицинский университет</institution></aff><aff xml:lang="en"><institution>Samara State Medical University</institution></aff></aff-alternatives><pub-date pub-type="collection"><year>2024</year></pub-date><pub-date pub-type="epub"><day>26</day><month>02</month><year>2024</year></pub-date><volume>86</volume><issue>1</issue><fpage>84</fpage><lpage>88</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Писарева Е.В., Власов М.Ю., Волова Л.Т., Ищенко К.С., Сергеева С.С., 2024</copyright-statement><copyright-year>2024</copyright-year><copyright-holder xml:lang="ru">Писарева Е.В., Власов М.Ю., Волова Л.Т., Ищенко К.С., Сергеева С.С.</copyright-holder><copyright-holder xml:lang="en">Pisareva E.V., Vlasov M.Y., Volova L.T., Ishchenko K.S., Sergeeva S.S.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.vestnik-vsuet.ru/vguit/article/view/3374">https://www.vestnik-vsuet.ru/vguit/article/view/3374</self-uri><abstract><p>Стресс увеличивает выработку стероидных гормонов глюкокортикоидов, которые усиливают процессы резорбции кости. Для лечения заболеваний костной ткани в медицине используются препараты, регулирующие фосфорно-кальциевый обмен в организме. Перспективным биоматериалом является минеральный компонент кости аллогенного происхождения, содержащий гидроксиапатит и аморфный фосфат кальция, способствующий усилению регенерации костной ткани за счет хорошей биосовместимости и стимуляция процессов костеобразования. В настоящей работе изучены параметры метаболизма костной ткани при ежедневном стрессовом воздействии высокой температуры и внутримышечном введении суспензии минерального компонента кости «Лиопласт» животным. Отмечено повышение кортизола и снижение активности щелочной фосфатазы в сыворотке крови животных, подвергнутых гипертермии. Активность щелочной фосфатазы в сыворотке крови в группе с гипертермией и группе плацебо снижалась в среднем на 25%. Активность фермента в группе животных, которым вводили костный компонент, статистически не отличалась от контрольного уровня. У животных, подвергшихся гипертермии на фоне введения минерального компонента кости, уровень паратгормона повышался одновременно с уровнем кальцитонина. Уровень паратгормона в сыворотке крови был ниже в группе с гипертермией, чем в контрольной группе. При этом уровень в группе с гипертермическим воздействием и введением минерального компонента кости был выше, чем в контроле, тем самым была установлена реципрокная связь между двумя гормонами - паратгормоном и кальцитонином. Таким образом, введение суспензии минерального компонента кости способствует снижению интенсивности остеорезорбции. Использование биоматериала, полученного оригинальным методом, способствует снижению интенсивности остеорезорбции в высокотемпературной модели. При введении суспензии минерального компонента кости остеодеструктивный эффект эндогенного приема глюкокортикоидов сглаживается и в значительной степени устраняется. С учетом высокого потенциала практического применения минерального компонента кости необходимы исследования его безопасности и эффективности на других биологических моделях с дальнейшим внедрением в клиническую практику.</p></abstract><trans-abstract xml:lang="en"><p>Stress increases the production of glucocorticoids, which enhance bone resorption processes. To treat bone tissue diseases, medicine uses drugs that regulate phosphorus-calcium metabolism. A promising biomaterial is a bone mineral component (BMC) of allogenic origin, containing hydroxyapatite and amorphous calcium phosphate, which enhances bone tissue regeneration. In this work the parameters of bone tissue metabolism were studied under daily stress exposure to high temperature and intramuscular administration of a suspension of bone mineral component “Lyoplast” to animals. There was an increase in cortisol and a decrease in alkaline phosphatase activity in the blood serum subjected to hyperthermia. Serum alkaline phosphatase activity in the hyperthermia group and the placebo group decreased by an average of 25%. The enzyme activity in animals that were injected with the bone component did not differ statistically from the control level. In animals exposed to hyperthermia due to the administration of a bone mineral component, the level of parathyroid hormone increased simultaneously with the calcitonin level. Serum parathyroid hormone levels were lower in the hyperthermia group than in the control one. А reciprocal relationship between two hormones, parathyroid hormone and calcitonin, has been established. Thus, the introduction of a suspension of the bone mineral component helps to reduce the intensity of osteoresorption. The use of biomaterial obtained by the original method helps to reduce the intensity of osteoresorption in the high-temperature model. With the introduction of a suspension of the bone mineral component, the osteodestructive effect of endogenous glucocorticoids is smoothed out and largely eliminated. Given the high potential for practical use of the bone mineral component, further research of its safety and effectiveness in other biological models is necessary with further implementation in clinical practice.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>высокая температура</kwd><kwd>минеральный компонент</kwd><kwd>костная ткань</kwd><kwd>кортизол</kwd><kwd>щелочная фосфатаза</kwd><kwd>паратгормон</kwd><kwd>кальцитонин</kwd><kwd>остеорезорбция</kwd></kwd-group><kwd-group xml:lang="en"><kwd>high temperature</kwd><kwd>mineral component</kwd><kwd>bone tissue</kwd><kwd>cortisol</kwd><kwd>alkaline phosphatase</kwd><kwd>parathyroid hormone</kwd><kwd>calcitonin</kwd><kwd>osteoresorption</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Kelly R.R., McDonald L.T., Jensen N.R. et al. Impacts of psychological stress on osteoporosis: clinical implications and treatment interactions. Front Psychiatry. 2019. no. 10. pp. 200.</mixed-citation><mixed-citation xml:lang="en">Kelly R.R., McDonald L.T., Jensen N.R. et al. Impacts of psychological stress on osteoporosis: clinical implications and treatment interactions. Front Psychiatry. 2019. no. 10. pp. 200.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Hang K., Ye C., Chen E.et al. Role of the heat shock protein family in bone metabolism. Cell Stress Chaperones. 2018. vol. 23. no. 6. pp. 1153–1164.</mixed-citation><mixed-citation xml:lang="en">Hang K., Ye C., Chen E.et al. Role of the heat shock protein family in bone metabolism. Cell Stress Chaperones. 2018. vol. 23. no. 6. pp. 1153–1164.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Takuma A., Kaneda T., Sato T. et al. Dexamethasone enhances osteoclast formation synergistically with transforming growth factor-beta by stimulating the priming of osteoclast progenitors for differentiation into osteoclasts. J Biol Chem. 2003. vol. 278. no. 45. pp. 44667–44674.</mixed-citation><mixed-citation xml:lang="en">Takuma A., Kaneda T., Sato T. et al. Dexamethasone enhances osteoclast formation synergistically with transforming growth factor-beta by stimulating the priming of osteoclast progenitors for differentiation into osteoclasts. J Biol Chem. 2003. vol. 278. no. 45. pp. 44667–44674.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Xi L., De Falco P., Barbieri E. et al. Reduction of fibrillar strain-rate sensitivity in steroid-induced osteoporosis linked to changes in mineralized fibrillar nanostructure. Bone. 2020. vol. 131. pp. 115111.</mixed-citation><mixed-citation xml:lang="en">Xi L., De Falco P., Barbieri E. et al. Reduction of fibrillar strain-rate sensitivity in steroid-induced osteoporosis linked to changes in mineralized fibrillar nanostructure. Bone. 2020. vol. 131. pp. 115111.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Urazgildeev Z.I., Bushuev O.M., Berchenko G.N. The use of a collapan for the plate of osteomyelitic bone defects. Bulletin of traumatology and orthopedics N.N. Priorov. 2006. no. 2. pp. 31–34.</mixed-citation><mixed-citation xml:lang="en">Urazgildeev Z.I., Bushuev O.M., Berchenko G.N. The use of a collapan for the plate of osteomyelitic bone defects. Bulletin of traumatology and orthopedics N.N. Priorov. 2006. no. 2. pp. 31–34.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Esmaeilkhanian A., Sharifianjazi F., Abouchenari A. et al. Synthesis and characterization of natural nano-hydroxyapatite derived from turkey femur-bone waste. Appl Biochem Biotechnol. 2019. vol. 189. no. 3. pp. 919–932.</mixed-citation><mixed-citation xml:lang="en">Esmaeilkhanian A., Sharifianjazi F., Abouchenari A. et al. Synthesis and characterization of natural nano-hydroxyapatite derived from turkey femur-bone waste. Appl Biochem Biotechnol. 2019. vol. 189. no. 3. pp. 919–932.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Podkovkin V.G., Pisareva E.V., Alenina N.V., The effect of high temperature on biochemical processes modified by perturbed geomagnetic field. Radiatsionnaia biologiia, radioecologiia. 2000. vol. 40. pp. 105–107.</mixed-citation><mixed-citation xml:lang="en">Podkovkin V.G., Pisareva E.V., Alenina N.V., The effect of high temperature on biochemical processes modified by perturbed geomagnetic field. Radiatsionnaia biologiia, radioecologiia. 2000. vol. 40. pp. 105–107.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Volova L.T., Podkovkin V.G., Pisareva E.V., Vlasov M.Yu. Bioimplant to restore the structure and volume of bone tissue. Patent RF, no. 2372892, 2008.</mixed-citation><mixed-citation xml:lang="en">Volova L.T., Podkovkin V.G., Pisareva E.V., Vlasov M.Yu. Bioimplant to restore the structure and volume of bone tissue. Patent RF, no. 2372892, 2008.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Deng S., Dai G., Chen S. et al. Dexamethasone induces osteoblast apoptosis through ROS-PI3K/AKT/GSK3β signaling pathway. Biomed Pharmacothe. 2019. vol. 110. pp. 602–608.</mixed-citation><mixed-citation xml:lang="en">Deng S., Dai G., Chen S. et al. Dexamethasone induces osteoblast apoptosis through ROS-PI3K/AKT/GSK3β signaling pathway. Biomed Pharmacothe. 2019. vol. 110. pp. 602–608.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Komori T. Glucocorticoid signaling and bone biology. Horm Metab Res. 2016. vol. 48. no. 11. pp. 755–763.</mixed-citation><mixed-citation xml:lang="en">Komori T. Glucocorticoid signaling and bone biology. Horm Metab Res. 2016. vol. 48. no. 11. pp. 755–763.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Wang T., Yu X., He C. Pro-inflammatory cytokines: cellular and molecular drug targets for glucocorticoid-induced-osteoporosis via osteocyte. Curr. Drug Targets. 2019. vol. 20. no. 1. pp. 1–15.</mixed-citation><mixed-citation xml:lang="en">Wang T., Yu X., He C. Pro-inflammatory cytokines: cellular and molecular drug targets for glucocorticoid-induced-osteoporosis via osteocyte. Curr. Drug Targets. 2019. vol. 20. no. 1. pp. 1–15.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Martin A., David V., Quarles L.D. Regulation and function of the FGF23/klotho endocrine pathways. Physiol Rev. 2012. vol. 92. no. 1. pp. 131–155.</mixed-citation><mixed-citation xml:lang="en">Martin A., David V., Quarles L.D. Regulation and function of the FGF23/klotho endocrine pathways. Physiol Rev. 2012. vol. 92. no. 1. pp. 131–155.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Lombardi G., Ziemann E., Banfi G., Corbetta S. Physical activity-dependent regulation of parathyroid hormone and calcium-phosphorous metabolism. Int J Mol Sci. 2020. vol. 21. no.15. pp. 5388.</mixed-citation><mixed-citation xml:lang="en">Lombardi G., Ziemann E., Banfi G., Corbetta S. Physical activity-dependent regulation of parathyroid hormone and calcium-phosphorous metabolism. Int J Mol Sci. 2020. vol. 21. no.15. pp. 5388.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Tian E., Watanabe F., Martin B., Zangari M. Innate biomineralization. Int J Mol Sci. 2020. vol. 21. no. 14. pp. 4820.</mixed-citation><mixed-citation xml:lang="en">Tian E., Watanabe F., Martin B., Zangari M. Innate biomineralization. Int J Mol Sci. 2020. vol. 21. no. 14. pp. 4820.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Confavreux C.B. Bone: from a reservoir of minerals to a regulator of energy metabolism. Kidney Int Suppl. 2011. vol. 79. no. 121. pp. 14–19.</mixed-citation><mixed-citation xml:lang="en">Confavreux C.B. Bone: from a reservoir of minerals to a regulator of energy metabolism. Kidney Int Suppl. 2011. vol. 79. no. 121. pp. 14–19.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Peri-Okonny P., Baskin K.K., Iwamoto G.et al. High-phosphate diet induces exercise intolerance and impairs fatty acid metabolism in mice. Circulation. 2019. vol. 139. no. 11. pp. 1422–1434.</mixed-citation><mixed-citation xml:lang="en">Peri-Okonny P., Baskin K.K., Iwamoto G.et al. High-phosphate diet induces exercise intolerance and impairs fatty acid metabolism in mice. Circulation. 2019. vol. 139. no. 11. pp. 1422–1434.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Chinnadurai R.K., Saravanaraman P., Boopathy R. The significance of aryl acylamidase activity of acetylcholinesterase in osteoblast differentiation and mineralization. Mol Cell Biochem. 2018. vol. 440 (1–2). pp. 199–208.</mixed-citation><mixed-citation xml:lang="en">Chinnadurai R.K., Saravanaraman P., Boopathy R. The significance of aryl acylamidase activity of acetylcholinesterase in osteoblast differentiation and mineralization. Mol Cell Biochem. 2018. vol. 440 (1–2). pp. 199–208.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Naot D., Musson D.S., Cornish J. The Activity of Peptides of the Calcitonin Family in Bone. Physiol Rev. 2019. vol. 99. no. 1. pp. 781–805.</mixed-citation><mixed-citation xml:lang="en">Naot D., Musson D.S., Cornish J. The Activity of Peptides of the Calcitonin Family in Bone. Physiol Rev. 2019. vol. 99. no. 1. pp. 781–805.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Weng S.J., Yan D.Y., Gu L.J., Combined treatment with vitamin K2 and PTH enhanced bone formation in ovariectomized rats and increased differentiation of osteoblast in vitro. Chem. Biol. Interact. 2019. vol. 300. pp. 101–110.</mixed-citation><mixed-citation xml:lang="en">Weng S.J., Yan D.Y., Gu L.J., Combined treatment with vitamin K2 and PTH enhanced bone formation in ovariectomized rats and increased differentiation of osteoblast in vitro. Chem. Biol. Interact. 2019. vol. 300. pp. 101–110.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Yao C.J., Lv Y., C.J. Zhang. MicroRNA185 inhibits the growth and proliferation of osteoblasts in fracture healing by targeting PTH gene through down-regulating Wnt/β – catenin axis: in an animal experiment. Biochem Biophys Res Commun. 2018. vol. 501. no. 1. pp. 55–63.</mixed-citation><mixed-citation xml:lang="en">Yao C.J., Lv Y., C.J. Zhang. MicroRNA185 inhibits the growth and proliferation of osteoblasts in fracture healing by targeting PTH gene through down-regulating Wnt/β – catenin axis: in an animal experiment. Biochem Biophys Res Commun. 2018. vol. 501. no. 1. pp. 55–63.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Matsumoto T., Kuriwaka-Kido R., Kondo T. Regulation of osteoblast differentiation by interleukin11 via AP1 and Smad signaling. Endocr J. 2012. vol. 59. no. 2. pp. 91–101.</mixed-citation><mixed-citation xml:lang="en">Matsumoto T., Kuriwaka-Kido R., Kondo T. Regulation of osteoblast differentiation by interleukin11 via AP1 and Smad signaling. Endocr J. 2012. vol. 59. no. 2. pp. 91–101.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Frenkel B., White W. Tuckermann J. Glucocorticoid-Induced Osteoporosis. Adv Exp Med Biol. 2015. vol. 872. pp. 179–215.</mixed-citation><mixed-citation xml:lang="en">Frenkel B., White W. Tuckermann J. Glucocorticoid-Induced Osteoporosis. Adv Exp Med Biol. 2015. vol. 872. pp. 179–215.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Delgado-Calle J., Sato A.Y., Bellido T. Role and mechanism of action of sclerostin in bone. Bone. 2017. vol. 96. pp. 29–37.</mixed-citation><mixed-citation xml:lang="en">Delgado-Calle J., Sato A.Y., Bellido T. Role and mechanism of action of sclerostin in bone. Bone. 2017. vol. 96. pp. 29–37.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
